Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation
Authors
Keywords
-Type amino acid transporter 1 (LAT1), Protein–ligand interactions, Structure–activity relationships (SAR), half-maximal uptake time (T, ½-max, )
Journal
BIOORGANIC CHEMISTRY
Volume 112, Issue -, Pages 104921
Publisher
Elsevier BV
Online
2021-04-23
DOI
10.1016/j.bioorg.2021.104921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure of the human LAT1–4F2hc heteromeric amino acid transporter complex
- (2019) Renhong Yan et al. NATURE
- Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc
- (2019) Yongchan Lee et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs)
- (2019) Johanna Huttunen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1)
- (2019) Natesh Singh et al. Scientific Reports
- Secondary Carbamate Linker Can Facilitate the Sustained Release of Dopamine from Brain-Targeted Prodrug
- (2018) Nikki A. Thiele et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1
- (2018) Natesh Singh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural properties for selective and efficient l -type amino acid transporter 1 (LAT1) mediated cellular uptake
- (2018) Jussi Kärkkäinen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health
- (2018) Mariafrancesca Scalise et al. Frontiers in Chemistry
- Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)
- (2018) Huan-Chieh Chien et al. JOURNAL OF MEDICINAL CHEMISTRY
- In silico Description of LAT1 Transport Mechanism at an Atomistic Level
- (2018) Luca Palazzolo et al. Frontiers in Chemistry
- L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs
- (2017) Elena Puris et al. JOURNAL OF CONTROLLED RELEASE
- LAT-1 activity of meta -substituted phenylalanine and tyrosine analogs
- (2016) Evan Augustyn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Selective and Slowly Reversible Inhibitor of l-Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells
- (2016) Kristiina M. Huttunen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure
- (2016) Mikko Gynther et al. NEUROCHEMICAL RESEARCH
- Insights into the molecular basis for substrate binding and specificity of the wild-type L-arginine/agmatine antiporter AdiC
- (2016) Hüseyin Ilgü et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantitative Insight into the Design of Compounds Recognized by theL-Type Amino Acid Transporter 1 (LAT1)
- (2014) Henna Ylikangas et al. ChemMedChem
- Transport of gabapentin by LAT1 (SLC7A5)
- (2013) David Dickens et al. BIOCHEMICAL PHARMACOLOGY
- Design, Synthesis and Brain Uptake of LAT1-Targeted Amino Acid Prodrugs of Dopamine
- (2013) Lauri Peura et al. PHARMACEUTICAL RESEARCH
- Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1
- (2013) E. G. Geier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure–activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion
- (2012) Henna Ylikangas et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis
- (2011) Mio Furuya et al. CANCER SCIENCE
- Large Amino Acid Transporter 1 (LAT1) Prodrugs of Valproic Acid: New Prodrug Design Ideas for Central Nervous System Delivery
- (2011) Lauri Peura et al. MOLECULAR PHARMACEUTICS
- High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions
- (2011) Masaaki Ichinoe et al. PATHOLOGY INTERNATIONAL
- Molecular basis of substrate-induced permeation by an amino acid antiporter
- (2011) L. Kowalczyk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain uptake of ketoprofen–lysine prodrug in rats
- (2010) Mikko Gynther et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Mechanism of substrate recognition and transport by an amino acid antiporter
- (2010) Xiang Gao et al. NATURE
- l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
- (2009) Koji Oda et al. CANCER SCIENCE
- Structure and Mechanism of an Amino Acid Antiporter
- (2009) X. Gao et al. SCIENCE
- Structure and Mechanism of a Na+-Independent Amino Acid Transporter
- (2009) P. L. Shaffer et al. SCIENCE
- Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
- (2008) K Kaira et al. BRITISH JOURNAL OF CANCER
- ENHANCED TUMOR GROWTH ELICITED BY L-TYPE AMINO ACID TRANSPORTER 1 IN HUMAN MALIGNANT GLIOMA CELLS
- (2008) Keiichi Kobayashi et al. NEUROSURGERY
- L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
- (2008) Takeshi Sakata et al. PATHOLOGY INTERNATIONAL
- Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung
- (2008) Kyoichi Kaira et al. PATHOLOGY RESEARCH AND PRACTICE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started